โ† All Topics / ade

FDA ADE reports for Capromorelin

ade_capromorelin_adverse_events

ade en 2026-07-22

Capromorelin โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Capromorelin is a active ingredient.

Total reports

Capromorelin: 1538

Reports by species (top entries)

  • Dog 770
  • Cat 474
  • Human 17
  • Ferret 1
  • Mouse 1
  • Primate 1

Top reported reactions (VEDDRA terms, top entries)

  • Lack of efficacy - NOS 258
  • Vomiting 180
  • Death by euthanasia 126
  • Lethargy (see also Central nervous system depression in 'Neurological') 117
  • UNPALATABLE 116
  • Hypersalivation 104
  • Behavioural disorder NOS 99
  • Death 96
  • Lethargy (see also Central nervous system depression in Neurological) 96
  • Diarrhoea 82

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b10.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).